Safety and performance of the next generation EnligHTN™ renal denervation system in patients with drug-resistant, uncontrolled hypertension: The EnligHTN III first-in-human multicentre study
Clinical Trials and Regulatory Science in Cardiology · 2015
DOI: 10.1016/j.ctrsc.2015.08.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Trials and Regulatory Science in Cardiology, 2015. Verfasst von Stephen G. Worthley und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: St. Jude Medical, Inc..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- St. Jude Medical, Inc.
Zitieren
APA
Worthley, S. G., Wilkins, G. T., Webster, M. W., Montarello, J. K., Antonis, P. R., Whitbourn, R. J., & Warren, R. J. (2015). Safety and performance of the next generation EnligHTN™ renal denervation system in patients with drug-resistant, uncontrolled hypertension: The EnligHTN III first-in-human multicentre study. Clinical Trials and Regulatory Science in Cardiology. https://doi.org/10.1016/j.ctrsc.2015.08.007
Vancouver
Worthley SG, Wilkins GT, Webster MW, Montarello JK, Antonis PR, Whitbourn RJ, et al. Safety and performance of the next generation EnligHTN™ renal denervation system in patients with drug-resistant, uncontrolled hypertension: The EnligHTN III first-in-human multicentre study. Clinical Trials and Regulatory Science in Cardiology. 2015. doi:10.1016/j.ctrsc.2015.08.007
BibTeX
@article{Worthley2015,
author = {Worthley, Stephen G. and Wilkins, Gerard T. and Webster, Mark W. and Montarello, Joseph K. and Antonis, Paul R. and Whitbourn, Robert J. and Warren, Roderic J.},
title = {Safety and performance of the next generation EnligHTN™ renal denervation system in patients with drug-resistant, uncontrolled hypertension: The EnligHTN III first-in-human multicentre study},
journal = {Clinical Trials and Regulatory Science in Cardiology},
year = {2015},
doi = {10.1016/j.ctrsc.2015.08.007}
}
EUVIMED